Scienture Ownership | Who Owns Scienture?
Scienture Ownership Summary
Scienture is owned by 0.05% institutional investors, and 99.95% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.21% of its assets in Scienture shares.
Institutional Shareholders
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2023 | 1 | -90.91% | 5,354 | -97.73% | - | 0.97% | - | -100.00% | - | -100.00% |
Mar 31, 2023 | 11 | -21.43% | 235,397 | -74.63% | 2 | 1.95% | 5 | -28.57% | 3 | -25.00% |
Dec 31, 2022 | 14 | 16.67% | 927,868 | 60.17% | 10 | 22.21% | 7 | 75.00% | 4 | 300.00% |
Sep 30, 2022 | 12 | -7.69% | 579,309 | -1.37% | 7 | 13.62% | 4 | -20.00% | 1 | -85.71% |
Jun 30, 2022 | 13 | 8.33% | 587,348 | 9.28% | 7 | 16.62% | 5 | -16.67% | 7 | 133.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 3.60K | 0.21% | -1.82K |
Vanguard Institutional Extnd Mkt Idx Tr | 14.55K | 0.17% | - |
Fidelity Total Market Index | 2.00K | 0.11% | - |
NT Ext Equity Mkt Idx Fd - L | 1.74K | 0.10% | -1.26K |
Northern Trust Extended Eq Market Idx | 1.74K | 0.10% | -1.26K |
NT Ext Equity Mkt Idx Fd - NL | 1.19K | 0.07% | - |
Fidelity Nasdaq Composite Index | 1.03K | 0.06% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 957.00 | 0.05% | 3.00 |
Spartan Extended Market Index Pool E | 913.00 | 0.05% | 54.00 |
Fidelity Series Total Market Index | 535.00 | 0.03% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 25, 2022 | Fell Donald G. | Buy | $1.62K | |
May 20, 2022 | AJJARAPU SURENDRA K | CEO | Buy | $13.00K |
May 20, 2022 | AJJARAPU SURENDRA K | CEO | Buy | $130.00M |
May 12, 2022 | Fell Donald G. | Buy | $2.52K | |
Jun 21, 2021 | PETERSON MICHAEL L | - | Sell | $4.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q1 | - | - |
2022 Q4 | - | - |
2022 Q3 | 1 | - |
2022 Q2 | 3 | - |
2021 Q2 | - | 3 |
MEDS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools